This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Booth, B. From the analyst's couch: valuation with cash multiples. Nature Rev. Drug Discov. 4, 533–534 (2005).
Beyond Borders: Ernst & Young Global Biotechnology Report (Ernst & Young, London, 2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, A., Clifford, L. Drug discovery alliances. Nat Rev Drug Discov 4, 807–808 (2005). https://doi.org/10.1038/nrd1856
Issue Date:
DOI: https://doi.org/10.1038/nrd1856
This article is cited by
-
The RA-MAP Consortium: a working model for academia–industry collaboration
Nature Reviews Rheumatology (2018)
-
Open innovation networks between academia and industry: an imperative for breakthrough therapies
Nature Medicine (2009)
-
Minimizing leakage of value from R&D alliances
Nature Reviews Drug Discovery (2007)
-
The 'not invented here' myth
Nature Reviews Drug Discovery (2006)